Abstract:Liver X receptors (LXRs) have been recognized as a promising therapeutic target for atherosclerosis; however, their role in insulin sensitivity is controversial. Adiponectin plays a unique role in maintaining insulin sensitivity. Currently, no systematic experiments elucidating the role of LXR activation in insulin function based on adiponectin signaling have been reported. Here, we investigated the role of LXR activation in insulin resistance based on adiponectin signaling, and possible mechanisms. C57BL/6 mice maintained on a regular chow received the LXR agonist, T0901317 (30 mg/kg.d) for 3 weeks by intraperitoneal injection, and differentiated 3T3-L1 adipocytes were treated with T0901317 or GW3965. T0901317 treatment induced significant insulin resistance in C57BL/6 mice. It decreased adiponectin gene transcription in epididymal fat, as well as serum adiponectin levels. Activity of AMPK, a key mediator of adiponectin signaling, was also decreased, resulting in decreased Glut-4 membrane translocation in epididymal fat. In contrast, adiponectin activity was not changed in the liver of T0901317 treated mice. In vitro, both T0901317 and GW3965 decreased adiponectin expression in adipocytes in a dose-dependent manner, an effect which was diminished by LXR alpha silencing. ChIP-qPCR studies demonstrated that T0901317 decreased the binding of PPAR gamma to the PPAR-responsive element (PPRE) of the adiponectin promoter in a dose-dependent manner. Furthermore, T0901317 exerted an antagonistic effect on the expression of adiponectin in adipocytes co-treated with 3 mu M Pioglitazone. In luciferase reporter gene assays, T0901317 dose-dependently inhibited PPRE-Luc activity in HEK293 cells co-transfected with LXR alpha and PPAR gamma. These results suggest that LXR activation induces insulin resistance with decreased adiponectin signaling in epididymal fat, probably due to negative regulation of PPAR gamma signaling. These findings indicate that the potential of LXR activation as a therapeutic target for atherosclerosis may be limited by the possibility of exacerbating insulin resistance-related disease.

Activating Transcription Factor 3, Glucolipid Metabolism, and Metabolic Diseases

The Dual Roles of Activating Transcription Factor 3 (ATF3) in Inflammation, Apoptosis, Ferroptosis, and Pathogen Infection Responses

Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism

Effects of Activating Transcription Factor 4 Deficiency on Carbohydrate and Lipid Metabolism in Mammals

ATF3 suppresses 3T3-L1 adipocyte adipogenesis via transcriptional repressing USP53

Activating transcription factor 5 regulates lipid metabolism in adipocytes

Identification of the Transcription Factor ATF3 as a Direct and Indirect Regulator of the LDLR

Activating Transcription Factor 3: A Potential Therapeutic Target for Inflammatory Pulmonary Diseases.

Loss of adipose ATF3 promotes adipose tissue lipolysis and the development of MASH

[The Role of Apolipoprotein C3 in the Regulation of Nonalcoholic Fatty Liver Disease, Glucose and Lipid Metabolism, and Islet Β Cell Function].

Biological Functions and Regulation of Adipose Triacylglyceride Lipase

ATF3 Regulates Osteogenic Function by Mediating Osteoblast Ferroptosis in Type 2 Diabetic Osteoporosis

The role of STAT3/VAV3 in glucolipid metabolism during the development of HFD-induced MAFLD

Regulation Of Insulin Resistance And Adiponectin Signaling In Adipose Tissue By Liver X Receptor Activation Highlights A Cross-Talk With Ppar Gamma

ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance

Activating transcription factor 3 coordinates differentiation of cardiac and hematopoietic progenitors by regulating glucose metabolism

Atf3-mediated metabolic reprogramming in hepatic macrophage orchestrates metabolic dysfunction–associated steatohepatitis

Adipose Triglyceride Lipase in Hepatic Physiology and Pathophysiology

Regulation of Hepatic Metabolism and Cell Growth by the ATF/CREB Family of Transcription Factors

Three Important Transcription Factors Related to Lipogenesis and Adipogenesis in Mammal

The Roles of ATF3, an Adaptive-Response Gene, in High-Fat-Diet-Induced Diabetes and Pancreatic Β-Cell Dysfunction